To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.
USA115th CongressHR-3991| House
| Updated: 10/16/2017
Michelle Lujan Grisham
Democratic Representative
New Mexico
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Expanded Access to Opioid Abuse Treatment Act of 2017 This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Law Enforcement
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnel
To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.
USA115th CongressHR-3991| House
| Updated: 10/16/2017
Expanded Access to Opioid Abuse Treatment Act of 2017 This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Michelle Lujan Grisham
Democratic Representative
New Mexico
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnel